FDA NDC Directory · JSON-LD · Markdown

Irinotecan hydrochloide

NDC 68001-480 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA212993
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsIRINOTECAN HYDROCHLORIDE (20 mg/mL)
Marketing started20201214
Package count2

External sources

Source: openFDA. Public-domain (CC0).